Delaware BIO Chairman of the Board Chris Yochim will accept the 2018 Ultimate Solution Award from PHL Life Sciences. Each year, the recognition goes to an individual or organization who has raised Philadelphia’s profile as a life sciences meeting and convention destination.
Yochim spent 35 years at AstraZeneca, creating partnerships and overseeing global external relations for the organization. As a founding member of the Delaware Bioscience Association, he has been instrumental in coalescing resources at the state level in order to attract and retain life sciences and pharmaceutical businesses. This has had a profound impact on the Delaware Valley, strengthening the region’s ties to the private sector and giving Philadelphia an edge when attracting major conventions, such as BIO International, which returns in 2019.
Yochim’s current role is a head of Business Development for the NIIMBL National Institute for Innovation in Manufacturing Biopharmaceuticals. NIIMBL is a national consortium of academia and industry. Its goal is to bring innovative solutions to real world challenges in manufacturing biological therapeutics.
Previous winners of the award include Former Philadelphia Mayor Michael Nutter (2015), American Association for Cancer Research (AACR) CEO Margaret Foti, Ph.D. (2016), and LabCorp CEO David King (2017).
Say hello to the PHLCVB’s newest destination marketing video, encapsulating the spirit of Philadelphia and the energy surrounding meetings and conventions held in the City of Brotherly Love.
Over the past few years, as we welcomed visitors from all over the globe during the World Meeting of Families in 2015, the Democratic National Convention in 2016, and NFL Draft in 2017, Philadelphia relished the opportunity to take center stage. The impact of our success has been realized through increased visitation and growing economic impact from the tourism sector.
For PHL Life Sciences, the video showcases “Freedom of Enlightenment” with cameos of the Pennovation Center, the University of Pennsylvania’s new technology incubator, and the Mütter Museum, home of many fascinating medical anomalies. There’s so much to see and do for convention- goers who are craving both educational and recreational experiences.
You’ll see that the video, much like Philadelphia, speaks for itself.
The MedTech Conference, which will be in Philadelphia for the first time from September 24-26, has added more star power to the speaker lineup: Johnson & Johnson Chairman and Chief Executive Officer Alex Gorsky.
The Pennsylvania Convention Center will host more than 3,000 of the medical technology industry’s top movers and shakers, executives and innovators. Critical to luring this major convention to Philadelphia? Relationships.
AdvaMed Executive Vice President Ray Briscuso worked with PHLCVB Convention Services, PHLCVB National Accounts Director Kevin Richards, PHL Life Sciences Executive Director Bonnie Grant and Life Sciences Pennsylvania over the course of several years to lay the groundwork and make meaningful connections. Briscuso is credited with growing BIO from 2,000 annual attendees to more than 18,000. BIO returns to Philadelphia in 2019.
In March 2018, AdvaMed announced a transition that makes the association full owner and operator of The MedTech Conference.
During the next three years, the University of Pennsylvania has agreed to invest up to $50 million in at least 10 biotech companies. The initiative is designed to spur medical and biological research projects at the Ivy League institution, with a “spill-over” effect into the larger Philadelphia innovation ecosystem.
With recent triumphs in cell and gene altering techniques at Penn, the fund will serve as a catalyst to commercialization, incentivizing outside firms to lend their financial support to promising technology in the region.
The underlying message from Penn: Philadelphia is a bankable destination for growth in the life sciences and pharmaceutical industries. The first investment – a $53 million deal for Carisma Therapeutics – brought together a syndicate investors, including AbbVie Ventures, HealthCap, IP Group, and Grazia Equity, among others.
With more than 14,000 physicians from 86 countries, the American College of Gastroenterology (ACG) is a leading membership organization for postgraduate training courses and scientific research in the field of digestive health and the etiology.
ACG’s Annual Scientific Meeting will leverage Philadelphia’s fertile academic and medical sectors in a program geared toward knowledge-sharing and networking. From October 5-10, the meeting will unfold in three parts: coursework, postgraduate certification programs, and the three-day meeting, all taking place at the Pennsylvania Convention Center.
ACG selected Philadelphia, in part, for its historical significance in the field of medical advancement. The city is home to many ‘firsts’ in the U.S., including the first medical school (University of Pennsylvania, est. 1765) and first hospital (Pennsylvania Hospital, est. 1751).
One of the leading associations for scientific, technical and regulatory advancement throughout the pharmaceutical lifecycle has decided to bring its annual meeting and expo to Philadelphia this fall, and again in 2020.
The International Society for Pharmaceutical Engineering (ISPE) will bring its membership, consisting of engineers, microbiologists, chemists, QA/QC, production, process development, pharmacists, regulatory and training personnel, and suppliers, to Philadelphia November 4-7, 2018. More than 3,000 will arrive at the Pennsylvania Convention Center to discuss tactics for delivering next generation therapies to the market, among many other industry developments. Workshops and educational programming will be led by pharmaceutical veterans from Johnson & Johnson, Merck & Co., Eli Lilly, and more.
An incentive for the group to commit to Philadelphia was the bevy of talent at their disposal, and the depth of corporate power in the region. One of the city’s ‘success stories’ will be spotlighted, as attendees have the opportunity to tour the office of Adaptimmune, a United Kingdom-based company using T-cell therapy to treat cancer, which recently built a $25 million facility in the city.
The country’s first and largest urban research park, the University City Science Center, has appointed Steve Zarrilli as chief executive officer. A facility for incubating life sciences technology, which opened up shop in 1963, has tapped a longtime leader with experience accelerating the development of growth- stage companies through venture capital deployment. Zarrilli is the former president and CEO of Safeguard Scientifics; he’ll be replacing Steve Tang, Ph.D., who led the organization since 2008.
The Science Center, with roots stretched underneath much of Philadelphia’s tech ecosystem, has a bold vision for invigorating University City and the surrounding neighborhoods. Their $1 billion deployment initiative, dubbed ‘uCitySquare’ is a rapidly-changing 10-acre parcel designed for hosting innovative biotech companies and commercializing research. BIO 2019 in Philadelphia will be an opportune time to tour the neighborhood, as it begins to take shape.
With the baby boomer generation nearing or crossing the threshold into retirement, healthcare and nursing services will begin to be tested. As this evolution occurs, and advocacy ramps up for the aging population, LeadingAge will ignite new conversations and actionable items with its 2018 Annual Meeting and Expo.
A kick-off concert by 90’s rock band Gin Blossoms on Sunday October 28 will open the doors to the four- day convention in Philadelphia. Dozens of speakers from around the country will discuss challenges faced and innovation in the field of nursing care. The “Vision Keynote” will be led by Harvard Business School Professor Frances Frel, who was Uber’s first senior vice president of leadership and strategy. Her research will examine how leaders create context for organizations and individuals to thrive. Philadelphia’s reputation as a dynamic city of medical prominence, allowed the city to host the organization’s 6,000 members.